FDA Grants Priority Review to Afami-Cel BLA in Advanced Synovial Sarcoma
The FDA has accepted for priority review the BLA seeking the approval of afamitresgene autoleucel for the treatment of advanced synovial sarcoma.
Source: onclive.com
Stay updated with breaking news from Afami Cel . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has accepted for priority review the BLA seeking the approval of afamitresgene autoleucel for the treatment of advanced synovial sarcoma.